[Pd(μ-I)(3-(CHO)C6H3CH=NCy)]2 | 174865-81-7

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: [Pd(μ-I)(3-(CHO)C6H3CH=NCy)]2
• CAS: 174865-81-7
• 化学式: C₂₈H₃₂I₂N₂O₂Pd₂
• 分子量: 895.223
• InChiKey: ZAISPQYNOKGLMM-UHFFFAOYSA-L

计算性质

• 辛醇/水分配系数(LogP)：
  None
• 重原子数：
  None
• 可旋转键数：
  None
• 环数：
  None
• sp3杂化的碳原子比例：
  None
• 拓扑面积：
  None
• 氢给体数：
  None
• 氢受体数：
  None

反应信息

• 作为反应物：
  描述：

  [Pd(μ-I)(3-(CHO)C6H3CH=NCy)]2 以 丙酮 为溶剂， 生成
  参考文献：
  名称：

  钯（II）的官能化环金属化配合物的反应性。[Pd {3-（CHO）C 6 H 3 C（H）NCy}（Br）（PEtPh 2）的晶体和分子结构

  摘要：

  环金属化配合物[{Pd [3-（CHO）C 6 H 3 C（H）NCy}（X）} 2 ]的处理[X = Cl（1），Br（2），I（3）]配合物/膦摩尔比为1：2或1：4的叔单膦化合物提供了卤化物桥接的裂解[Pd {3-（CHO）C 6 H 3 C（H）NCy}（X）（L）]（6 – 17）和非环金属化的配合物[Pd {3-（CHO）C 6 H 3 C（H）NCy}（X）（L）2 ]（18 – 23）（X = Cl，Br或I； L = PPH 3，PEtPh 2，PET 2 PH或PMePh2）。的反应6 - 17 1或1：1：2的摩尔比，得到[钯{3-（CYC（H）N）C与环己1在复杂/胺6 ħ 3 C（H）NCy}（X）（ L）]（24 – 28）和非环金属化的[Pd {3-（CyC（H）N）C 6 H 3 C（H）NCy}（X）（L）（NH 2 Cy）]（29 – 32

  DOI：

  10.1016/s0022-328x(97)00687-6
• 作为产物：
  描述：

  [Pd(mu.-OAc)(3-(CHO)C6H3CH=NCy)]2 、 sodium iodide 以 水 、 丙酮 为溶剂， 以83%的产率得到[Pd(μ-I)(3-(CHO)C6H3CH=NCy)]2
  参考文献：
  名称：

  Synthesis and characterization of cyclometallated complexes of palladium(II) and manganese(I) with bidentate Schiff bases

  摘要：

  Treatment of N,N-isophthalylidenebis(cyclohexylamine) 1,3-(CyN=CH)(2)C6H4(L(2)) (Cy = cyclohexyl) with palladium(II) acetate in glacial acetic acid gave after column chromatography the monocyclometallated dimer complex [{Pd[3-(CHO)C6H3C(H)=NCy][O(2)CMe)}(2)] (1) with a free formyl group on each phenyl ring, and a mixture of 1 with the doubly cyclometallated complex [Pd(3-(CyN=CH)C6H3C(H)=NCy)(O(2)CMe)] (2). Treatment of 1 with cyclohexylamine gave the corresponding dimer complex [{Pd[3-(CyN=CH)C6H3C(H)=NCy](O(2)CMe)}(2)] (17) with an uncoordinated C=N group on each phenyl ring. Treatment of 1 and 2 with aqueous NaX gave the dimer complexes [{Pd[3-(CHO)C6H3C(H)=NCy]{(X)}(2)] (3: X = Cl; 4: X = Br; 5: X = I) and a mixture of 3, 4 or 5 with the doubly cyclometallated complex [Pd[3-(CyN=CH)C6H3O(H)=NCy](X)] (6: X = Cl; 7: X = Br; 8: X = I), respectively. The dicydometallated iodo complex 8 was isolated pure. Treatment of 3, 4 or 5 with cyclohexylamine in a 1:2 or 1:4 molar ratio gave the cyclometallated complexes [Pd[3-(CHO)C6H3C(H)=NCy](X)(NH(2)Cy)] (9: X = Cl; 10: X = Br; 11: x = I) and [Pd[3-(CyN=CH)C6H3O(H)=NCy](X)(NH(2)Cy)] (12: X = Cl; 13: X = Br; 14: X = I), respectively; the last three compounds 6 each contain an uncoordinated C=N group. The corresponding bromo and iodo analogues were made similarly. Treatment of 3, 4 or 5 with thallium cyclopentadienyl or thallium acetylacetonate gave the mononuclear complexes [Pd[3-(CHO)C6H3C(H)=NCy)(C5H5)] (15) and [Pd{3-(CHO)C6H3C(H)=NCy)(H3CCOCHCOCH3)] (16), respectively. Treatment of L(2) with MnMe(CO)(5) in a 1.1 molar ratio gave the monocyclometallated complex [(OC)(4)Mn{3-(CHO)C6H3C(H)=NCy}] (18) by cleavage of one C=N bond, whereas treatment of L(2) with MnMe(CO)(5) in a 1:1.2 molar ratio produced a mixture of the doubly cyclometallated complex 19 and the monocyclometallated complex 20 without cleavage of the C=N bond. Treatment of N,N-terephthalylidenebis(cyclohexylamine), 1,4-(CyN=CH)(2)C6H4(L(1)) (Cy = cyclohexyl), with MnMe(CO)(5) in a 1:1.2 molar ratio gave a mixture of the monocyclometallated compound [(OC)(4)Mn{4-(CHO)C6H3C(H)=NCy}] (22) and the monocyclometallated compound [(OC)(4)Mn{4-(CyN=CH)C6H3C(H)=NCy}] (23); compound 22 was isolated in a pure state.

  DOI：

  10.1016/0022-328x(95)05691-h